Post-tachycardia QT prolongation: Maladjustment of the QT interval to the normal heart rate

PACE - Pacing and Clinical Electrophysiology

Volumn 26, Issue 3, 2003, Pages 659-661

  Viskin, Sami ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; QUINIDINE;

ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; CARDIOMYOPATHY; CATHETER ABLATION; DISEASE COURSE; DRUG TOLERABILITY; EDITORIAL; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE FAILURE; HEART RATE; HEART REPOLARIZATION; HEART VENTRICLE PACING; HOSPITAL CHARGE; HUMAN; LONG QT SYNDROME; QT INTERVAL; RISK FACTOR; RR INTERVAL; SINUS RHYTHM; SUDDEN DEATH; TACHYCARDIA; TORSADE DES POINTES;

ANIMALS; CARDIAC PACING, ARTIFICIAL; CATHETER ABLATION; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; PACEMAKER, ARTIFICIAL; TACHYCARDIA;

EID: 0037354282     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2003.00114.x     Document Type: Editorial

References (27)

1. Shinbane JS, Wood MA, Jensen DN, et al. Tachycardia-induced cardiomyopathy: A review of animal models and clinical studies. J Am Coll Cardiol 1997; 29:709-715.
2. Geelen P, Brugada J, Andries E, et al. Ventricular fibrillation and sudden death after radiofrequency catheter ablation of the atrioventricular junction. PACE 1997; 20:343-348.
3. Darpo B, Walfridsson H, Aunes M, et al. Incidence of sudden death after radiofrequency ablation of the atrioventricular junction for atrial fibrillation. Am J Cardiol 1997; 80:1174-1177.
4. Azar KR, Lippman N, Kluger J. Recurrent polymorphic ventricular tachycardia complicating radiofrequency catheter ablation of the atrioventricular junction. PACE 1998; 21:1837-1840.
5. Peters RHJ, Wever EFD, Hauer RNW, et al. Bradycardia dependent QT prolongation and ventricular fibrillation following catheter ablation of the atrioventricular junction with radiofrequency energy. PACE 1994; 17:108-112.
6. Roden D, Woosley R, Primm R. Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient care. Am Heart J 1986; 111:1088-1093.
7. Morady F, Hasse C, Strickberger SA, et al. Long-term follow-up after radiofrequency modification of the atrioventricular node in patients with atrial fibrillation. J Am Coll Cardiol 1997; 29:113-121.
8. Pinski SL, Murphy J, Haw J, et al. Lethal ventricular arrhythmias following one-step pacemaker reprogramming for rapid tracking of atrial tachyarrhythmias. Am J Cardiol 2001; 87:349-350.
9. Wesley RC, Turnquest P. Torsade de pointes after intravenous adenosine in the presence of prolonged QT syndrome. Am Heart J 1992; 123:794-796.
10. Cellarier G, Deharo JC, Chalvidan T, et al. Prolonged QT interval and altered QT/RR relation early after radiofrequency ablation of the atrioventricular junction. Am J Cardiol 1999; 83:1671-1673.
11. Kaab S, Nuss HB, Chiamvimonvat V, et al. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res 1996; 78:262-273.
12. Rozanski GJ, Xu Z, Whitney RT, et al. Electrophysiology of rabbit ventricular myocytes following sustained rapid ventricular pacing. J Mol Cell Cardiol 1997; 29:721-732.
13. Lacroix D, Gluais P, Marquie C, et al. Repolarization abnormalities and their arrhythmogenic consequences in porcine tachycardia-induced cardiomyopathy. Cardiovasc Res 2002; 54:42-50.
14. Sato T, Hata Y, Yamamoto M, et al. Early afterdepolarization abolished by potassium channel opener in a patient with idiopathic long QT syndrome. J Cardiovasc Electrophysiol 1995; 6:279-282.
15. Krebs ME, Szwed JM, Shinn T, et al. Short-term rapid ventricular pacing prolongs ventricular refractoriness in patients. J Cardiovasc Electrophysiol 1998; 9:1036-1042.
16. Vos MA, De-Groot SHM, Verduyin SC, et al. Enhanced susceptibility for acquired torsade de pointes arrhythmias in the dog with chronic, complete AV block is related to cardiac hypertrophy and electrical remodeling. Circulation 1998; 98:1125-1135.
17. Satoh T, Zipes DP. Rapid rates during bradycardia prolong ventricular refractoriness and facilitate ventricular tachycardia induction with cesium in dogs. Circulation 1996; 94:217-227.
18. Jackman WM, Szabo B, Friday KJ, et al. Ventricular tachyarrhythmias related to early afterdepolarizations and triggered firing: Relationship to QT interval prolongation and potential therapeutic role for calcium channel blocking agents. J Cardiovasc Electrophysiol 1990; 1:170-195.
19. Roden DM, Anderson ME. The pause that refreshes, or does it? Mechanisms in torsades de pointes. Heart 2000; 84:235-237.
20. Conti JB, Mills RM, Woodard DA, et al. QT-dispersion is a marker for life-threatening ventricular arrhythmias after atrioventricular nodal ablation using radiofrequency energy. Am J Cardiol 1997; 79:1412-1414.
21. Yang R, Kanki H, Drolet B, et al. Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation 2002; 105:1943-1948.
22. Kurita T, Ohe T, Marui N, et al. Bradycardia-induced abnormal QT prolongation in patients with complete atrioventricular block with torsades de pointes. Am J Cardiol 1992; 69:628-633.
23. Raj SR, Gillis AM, Mitchell B, et al. Paced QT dispersion and QT morphology after radiofrequency AV junction ablation: Impact of left ventricular function. PACE 2003; 26:662-668.
24. Jackman WM, Friday KJ, Anderson JL, et al. The long QT syndromes: A critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis 1988; 31:115-172.
25. Viskin S, Heller K, Barron HV, et al. Post-extrasystolic U-wave augmentation: A new marker of increased arrhythmic risk in patients without prolonged QT syndrome. J Am Coll Cardiol 1996; 28:1746-1752.
26. Viskin S. Cardiac pacing in the long QT syndrome. Review of available literature and practical recommendations. J Cardiovasc Electrophysiol 2000; 11:593-600.
27. Viskin S, Glikson M, Fish R, et al. Rate smoothing with cardiac pacing for preventing torsade de pointes. Am J Cardiol 2000; 86(9 Suppl.1):K111-K115.